EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the companys board of directors granted three new employees restricted stock units to acquire 38,500 shares of the companys…

Click here to view the original article.